Episode 087: Prostate Cancer Series: Pt. 4- Radiation Oncology in Prostate Cancer

Episode 087: Prostate Cancer Series: Pt. 4- R...

Up next

Episode 145: Myeloma Series, Pt. 6 - First line treatment of Multiple Myeloma (2026)

This week, we begin our discussion about treatment of multiple myeloma, focusing on the first-line setting. Once again, a lot has changed in this space over the last few years, most notably the standards of care (now quadruplet regimens instead of triplet regimens!). We break dow ...  Show more

Episode 144: Myeloma Series, Pt. 5 - Myeloma Risk Stratification and Response Criteria (2026)

This week, we introduce a new episode for our myeloma series, this time focusing on risk stratification and response criteria. The initial workup and surveillance labs are expansive, but all of the studies we do have a purpose. Many present-day studies also use “minimal residual ...  Show more

Recommended Episodes

#343 – The evolving role of radiation: advancements in cancer treatment, emerging low-dose treatments for arthritis, tendonitis, and injuries, and addressing misconceptions | Sanjay Mehta, M.D.
The Peter Attia Drive

View the Show Notes Page for This Episode

<a href= "https://peterattiamd.com/subscribe/?utm_s ...

  Show more

Episode 165: A Radiation Oncology Perspective on the PROSPECT Trial
Healthcare Unfiltered

Salma Jabbour, MD, Professor and Vice Chair of Radiation Oncology at Rutgers Cancer Institute, provides an invaluable perspective rooted in her extensive experience and passion for radiation oncology. Dr. Jabbour delves into the transformative changes witnessed in radiation oncol ...  Show more

Colorectal Cancer
Ninja Nerd

Send us a textNinja Nerds!In this episode of the Ninja Nerd Podcast, Zach and Rob discuss Colorectal Cancer. This comprehensive discussion focuses on the clinical presentation, pathogenesis, and management of one of the most common malignancies encountered in clinical practice.We ...  Show more

Episode 288: APCCC #3: Controversies around Radiotherapy
The Uromigos

Thomas Zilli discusses controversies around radiotherapy in prostate cancer.